Clinical Trial Update: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating miltefosine-based therapy for cutaneous leishmaniasis in the New World has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Cutaneous Leishmaniases | Phase 3 | Status: COMPLETED